Heparin-Induced Thrombocytopenia

Suitable for clinicians and hematology consultants, this title includes: coverage of approved and novel pharmacotherapies, dosing guidelines, and the advantages and limitations of alternative anticoagulants; review of the immune basis and pathogenesis, animal models, and laboratory testing for HIT antibodies; and more.